Developmental and cancer biologists have long pondered how cell proliferation is restricted, first during embryogenesis to allow morphogenesis and later in adults to maintain homeostasis. I use the term "restricted," rather than "promoted" because, although it is often assumed that cells must be stimulated to proliferate, the basal state of the single-celled eukaryotes that gave rise to metazoa was almost certainly one of proliferation, limited only by nutrients. With the arrival of multicellularity came the requirement that cells acquire characteristics akin to cooperation and altruism, such as the ability to restrain their growth and division in response to signals from other cells and to die when no longer needed. These properties are essential for proper development and for maintaining homeostasis in adults. Acquiring them necessitated the establishment of new mechanisms to allow cells to sense their density or numbers and to apply this information to regulate intrinsic cellular processes including growth, division, and survival. Although it is clear that genetic systems controlling cell numbers are vulnerable (consider cancer as an example), we are still far from understanding how these systems operate during normal development. In this review, I highlight some recent advances relevant to this puzzle.
A New Signaling Complex
The advent of modern methods for generating genetic mosaics in the fruit fly Drosophila melanogaster (Xu and Rubin, 1993) prompted screens in which clones of cells with mutations in random genes were produced, and the adults were scored for abnormal tumor-like growths. These screens identified many genes that, when mutated, caused the inappropriate proliferation of cells. Many of these genes turned out to be orthologs of known or suspected human tumor-suppressor genes, such as PTEN or TSC2. Studies of these genes in Drosophila have proven useful for assigning functions to the proteins they encode and mapping their signaling pathways. Some new growth suppressors were also discovered. The first of these was warts/large tumor suppressor (wts/lats), a kinase of the nuclear Dbf-2-related (NDR) family (Justice et al., 1995; Xu et al., 1995) . Cells with mutations in the wts gene exhibit dramatic outgrowths in a variety of fly epithelial tissues but do not display overt changes in cell identity or the ability to differentiate. Further screens isolated three other geneshippo (hpo), salvador (sav), and mob as tumor suppressor (mats)-that gave strikingly similar tumorous phenotypes when clonally deleted in developing eyes, wings, or legs of the fly (Harvey et al., 2003; Kango-Singh et al., 2002; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003 , Lai et al., 2005 .
The similarities among the phenotypic effects caused by mutations in these four genes suggested that they might function in a common pathway. When deleted in wing epithelial cells, each of them causes a cell shape change termed apical hypertrophy, in which the apical cell surface expands away from the nucleus, taking on a domed shape, and areas of apical-lateral adhesion are reduced (Justice et al., 1995) . These apical-lateral regions are where adherens junctions reside in insect epithelia, suggesting that this set of genes affects the function of adherens junctions (Bilder, 2004; Perez-Moreno et al., 2003) . Clones of mutant cells produced in the wing or eye primordia (called "discs") also exhibit smooth borders and a rounded shape, indicative of altered cell adhesion, although cell polarity and organization of the epithelial monolayer are maintained. Prior to differentiation, the mutant cells were also observed to grow and divide more rapidly than normal cells, without any change in cell size. A distinct effect was noted in the eye, where mutations in hpo, sav, or wts each cause inappropriate proliferation and survival of nonneural interommatidial cells just after
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differentiation. This suggested a common function for these genes during eye development (see Figure  1) . Normally, interommatidial cells are produced in excess, and most of them are culled in a wave of apoptosis during eye differentiation. In hpo, sav, or wts mutants, these interommatidial cells fail to die but instead divide several extra times, causing expansion and some disorganization of the eye. Mutations in the mats gene were reported to cause a somewhat more severe phenotype, in which differentiation was abrogated and, perhaps as a result, substantial apoptosis occurred at late stages (Lai et al., 2005) . When very large cell clones with mutations in wts or hpo were produced, however, they too showed pronounced defects in cell differentiation (Wu et al., 2003; Xu et al., 1995) , suggesting that the severe phenotype conferred by mats mutations may not actually reflect a distinct function. The cause of these differentiation defects is unclear, but given that they vary according to clone size, they could be due to the failure of the mutant cells to effectively transduce long-range differentiation signals.
Given these similarities in mutant phenotypes, perhaps it is not surprising that the Hippo and Sav proteins were found to physically interact with each other, as were the Warts and Mats proteins (see Figure 2) . Biochemical assays showed that Hippo, a Ste-20/MST2 type kinase, phosphorylates and activates Warts and that Sav, a WW-repeat protein, facilitates this reaction potentially by acting as a scaffold. Furthermore, Mats was found to bind to Warts, but not to Hippo, and to stimulate Warts kinase activity. Genetic tests performed in vivo supported these interactions. Mats has also been shown to physically and genetically interact with another NDR-family kinase, tricornered (trc), which is required for the morphogenesis of epidermal hairs, bristles, and dendrites (He et al., 2005) . This might explain the relative severity of the mats mutant phenotype.
Downstream of Hippo and Warts
Targeted searches for downstream effectors revealed that the loss of hpo, sav, wts, or mats caused a cell-autonomous increase in the amounts of the Drosophila inhibitor of apoptosis gene product, DIAP-1, and the cell cycle regulator Cyclin E (Harvey et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003) . DIAP-1 and Cyclin E are important regulators of cell survival and cell cycle progression, respectively, and thus they probably account, at least in part, for the survival and continued proliferation of cells with mutations in these genes. Other potential clues to function have come from studies of the mammalian Warts orthologs, LATS1 and LATS2/ Kpm, which implicate both proteins in the regulation of mitosis. LATS1 and LATS2/ Kpm are phosphorylated and activated in mitosis, and when overexpressed they can bind to and inhibit the mitotic kinase Cdk1 Yang et al., 2001; Xia et al., 2002; Kamikubo et al., 2003; Iida et al., 2004) . This suggests a possible explanation for LATS-dependent growth suppression. Perhaps more importantly, loss-of-function studies revealed that cells lacking LATS1 or LATS2 exhibit defects in exiting mitosis (Bothos et al., 2005) and in cytokinesis (Yang et al., 2004; McPherson et al., 2004) that lead to multinucleate cells, centrosome amplification, and genomic instability. Functions in mitosis or cytokinesis might contribute to the tumor-suppressor activity of the LATS genes in mammals (Takahashi et al., 2005; St. John et al., 1999) , but such defects do not provide a ready explanation for the increased cell growth and survival seen in wts mutant cells in Drosophila. Moreover, as mitotic defects have not been observed in fly cells with mutations in wts, hpo, sav, or mats, these functions may be specific to the mammalian LATS1 and LATS2 genes.
Thus, despite the intriguing overgrowth phenotypes conferred by loss of genes encoding Hippo complex components, Hippo has until recently remained an orphan signaling entity, lacking known upstream inputs and, for the most part, critical downstream effectors. Given that the Hippo and Warts complexes could not easily be slotted into any known signaling pathway, it was assumed that they must define a new signaling pathway important for containing proliferation, at least in epithelial cells. Although the increase in Cyclin E and DIAP-1 may explain the boost in cell numbers seen in mutant tissues, these two target molecules cannot explain the stimulation of cell growth (increased cell mass) or the intriguing cell shape and adhesion defects displayed by these cells. Moreover, how the Warts kinase complex controls even its known targets (cyclin E, diap-1) is not obvious, with some researchers suggesting transcriptional control and others favoring regulation at the protein level. Two recent papers have redrawn this lonely scene, adding a downstream effector (Huang et al., 2005) , some upstream inputs (Hamaratoglu et al., 2005) , and an interesting feedback loop.
The downstream effector, Yorkie (Yki), was discovered by Duojia "DJ" Pan's group not by phenotypic screens in flies but by virtue of its ability to bind to Warts in a yeast twohybrid screen (Huang et al., 2005) . Yorkie is the Drosophila ortholog of YAP (Yes-associated protein), which has been characterized as a non-DNA binding transcriptional coactivator in mammalian cells (Yagi et al., 1999) . Yorkie fulfills all of the criteria required of a Warts effector: it not only binds to Warts but appears to recapitulate all of its tumorsuppressor functions when overexpressed in cell clones in developing wings and eyes of the fly. Moreover, loss-offunction mutations in yki arrest cell growth and are epistatic for hpo and wts, meaning that hpo, yki, or wts, yki doublemutant cells grow just as poorly as yki single-mutant cells. This suggested that the Hippo/Sav and Warts/Mats complexes might act upstream of Yorkie as negative regulators, and indeed, they were shown experimentally to suppress transcriptional activation by Yorkie. Biochemical analysis of cultured Drosophila cells showed that Yorkie is phosphorylated by Warts in a Hippo/Sav-dependent fashion, suggesting that Warts normally suppresses Yorkie activity by phosphorylating it. The specific role, if any, that phosphorylation plays in regulating the activity of Yorkie remains to be determined.
The discovery of Yorkie is a substantial advance because it will allow the identification of the binding partners that bring it to the promoters of target genes. This will facilitate the comprehensive cataloging of Hippo/Warts targets that are regulated transcriptionally. Given the near-complete phenocopy of wts, hpo, and sav mutant phenotypes by overproduced Yorkie, this may cover most of the relevant targets and thus explain the cell adhesion, cell shape, and growth effects of the pathway, which are presently mysterious. The study from Huang et al. (2005) may provide the means to answer other pressing questions about the Hippo pathway. For instance, it has been suspected that Hippo/ Warts activity may increase as cells differentiate, thereby suppressing proliferation and promoting apoptosis, but so far there has been little evidence that the pathway is subject to spatiotemporal regulation at the onset of differentiation. Despite the observation that it has more profound effects in differentiating cells than proliferating ones, and in some cell types (interommatidial) than others (photoreceptors), all Hippo pathway components appear to be uniformly expressed during the stages of eye development when the mutant phenotypes unfold. Assays of Yorkie activity, most likely using phosphospecific antibodies but potentially based on Yorkie nuclear localization or yki reporter gene expression, may reveal how the Hippo pathway is regulated in space and time during development.
Such studies are likely to uncover considerable complexity, as evidenced by a striking recent report showing that Warts, Hippo, and Sav play a second role as essential regulators of photoreceptor cell type choice in the postmitotic Drosophila eye (Mikeladze-Dvali et al., 2005) . In this case, the transcriptional targets, which might again be regulated by Yorkie, are rhodopsin genes essential for color vision and have no apparent relevance to growth suppression. This suggests that Yorkie probably activates distinct sets of genes using different DNA binding partners and that its spectrum of targets will vary greatly according to developmental stage and cellular context. Interestingly, MikeladzeDvali et al. (2005) also found that wts transcript expression correlated with photoreceptor cell type and was regulated by a conserved pleckstrin-homology (PH) domain-containing protein, Melted, in a bistable loop in which Melted and Warts can mutually repress each other at the transcriptional level. This loop ensures that photoreceptors express either Melted and one rhodopsin isoform (rh5, used for shorter wavelength colors) or Warts and a different rhodopsin isoform (rh6, used for longer wavelength colors), to guarantee that no cells express both rhodopsins simultaneously. Interactions between melted and wts, or cell type-specific transcription of wts, have not yet been noted during the growth phase in the eye or other organs.
Up the Nile
This leads us to another mystery that has dogged researchers in this field for several years: what are the upstream inputs that regulate the Hippo/Warts pathway, if it is regulated? Again, to the chagrin of the fly geneticists, forward genetic screens gave few clues. A candidate gene approach taken by Georg Halder's group, however, recently provided a lead that should help to focus the search (Hamaratoglu et al., 2005) . This study followed up on earlier work (McCartney et al., 2000) that showed that cells doubly mutant for two genes that encode band 4.1 superfamily proteins, merlin and expanded, exhibited epidermal outgrowths similar to those caused by loss of hpo, wts, or sav. merlin and expanded encode members of the ezrin/radixin/moesin (ERM) family of FERM domain-containing proteins. They are partially redundant for function and can form heterodimeric complexes. Both proteins localize adjacent to adherens junctions and are thought to link transmembrane proteins to the actin cytoskeleton (Bretscher et al., 2002; Sun et al., 2002; McClatchey and Giovanni, 2005) . expanded mutants exhibit mild overgrowth phenotypes in flies (Boedigheimer et al., 1997; , and mammalian fibroblasts and endothelial cells lacking Merlin, encoded by the neurofibromatosis 2 (NF2) tumorsuppressor gene, are resistant to contact inhibition of proliferation (Lallemand et al., 2003; Okada et al., 2005) . Interestingly, Lats2 mutant mouse embryonic fibroblasts also exhibit this defect (McPherson et al., 2004 ), suggesting that LATS2 may act downstream of Merlin in mammals as its ortholog, Warts, does in Drosophila (see below).
In flies, the overgrowth phenotype of merlin, expanded double-mutant cells is much more severe than that caused by either single mutant. Notably, the double-mutant phenotype is strikingly similar to that conferred by loss of wts, hpo, or sav (see Figure 1) . When generated in the Drosophila eye, merlin, expanded double-mutant cells grow into smooth-bordered clones that proliferate inappropriately during the differentiation phase and then evade the normal wave of apoptosis that culls excess interommatidial cells. As with hpo and wts complex mutants, merlin, expanded double-mutant cells also sustain increased transcription of cyclin E and diap-1. Hamaratoglu et al. (2005) went on to use a clever battery of epistasis tests to show that hpo and wts are required for and act genetically downstream of merlin and expanded in containing growth and culling excess interommatidial cells at differentiation. For instance, overexpressed expanded promoted apoptosis but was incapable of doing so in hpo mutant tissue. Biochemical tests indicated that Merlin and Expanded do not bind directly to Hippo, Sav, or Warts; however, they do stimulate the phosphorylation of Warts by Hippo and thereby probably activate Warts to signal downstream. Consistent with this notion, transcriptional activation by Yorkie was shown to be suppressed by high levels of Merlin and Expanded. How these ERM proteins stimulate the interaction between Hippo and Warts is still unclear. Intermediate factors are likely involved, but the general implication is that the Hippo and Warts kinases communicate cues reflecting cell structure, emanating from Merlin and Expanded, to the nucleus via Yorkie (see Figure 2) .
Searching for the Source
Although the control of the Hippo complex by ERM family proteins extends the pathway upstream a step, the exact source of the input signals is still murky. Merlin can heterodimerize with Ezrin (in humans) or Expanded (in Drosophila), and it has been reported to bind numerous factors that have potential functional relevance. These include cytoskeletal actin, β-catenin, βII-spectrin, phosphatidylinositol (4,5)-bisphosphate (PIP 2 ), paxillin, and several transmembrane proteins such as (in humans) CD44, a receptor for the extracellular matrix component hyaluronic acid (Sun et al., 2002; McClatchey and Giovanni 2005) . Most of these binding capabilities reside in the FERM domain of Merlin, which is highly conserved in metazoa and distinct from those of other ERM family members (Golovnina et al., 2005) . ERM proteins including Merlin can switch between open (unfolded) and closed (self-binding) states dependent upon phosphorylation, protein-protein interactions, and mutations such as those in the human Merlin/NF2 gene that cause neurofibromatosis. This conformational change is believed to determine Merlin's interactions with its binding partners, and it is the closed, hypophosphorylated conformation that appears to exert growth-suppressive activity. Levels of hypophosphorylated Merlin increase upon loss of adhesion in cultured (NIH 3T3) cells, and levels of both the hypo-and hyperphosphorylated protein increase dramatically when such cells become confluent, or are deprived of serum growth factors (Shaw et al., 1998) . These changes are assumed to accompany increased Merlin activity since they are associated with growth arrest. Similar changes in the growth suppressive activity of Merlin have not yet been described in differentiating tissues in vivo but will be very interesting to look for.
The aforementioned findings have suggested that Merlin might integrate growth stimulatory and inhibitory signals from transmembrane receptors like CD44 and the EGFR or adhesion molecules such as the cadherins (Sun et al., 2002; McClatchey and Giovanni 2005) , but so far the functional data to support this attractive hypothesis is somewhat limited. Of note are studies performed in fibroblasts and endothelial cells showing that Merlin acts in a mutually antagonistic loop with p21-activated kinase (PAK) and its activator, the small GTPase Rac (Shaw et al., 2001; Okada et al., 2005) . Merlin phosphorylation is Rac and PAK dependent, whereas the cortical localization (and presumed activity) of Rac can be suppressed by Merlin. Of particular significance is the observation that activated forms of PAK or Rac can release human endothelial cells from contact inhibition, just as does loss of Merlin activity (Lallemand et al., 2003) , and that an activated variant of Merlin can block this effect. Since Rac activity can be stimulated by growth factors via integrins and receptor tyrosine kinases, several authors have suggested that Merlin activity is suppressed by such signals, at least at low cell density. At high cell den- Parts of two epithelial cells are shown, with Merlin (Mer) and Expanded (Ex) interacting with plasma membrane proteins (identity unknown) and the actin cytoskeleton and transducing a signal that stimulates the phosphorylation of Warts (Wts), which is in a complex with Mats (Mob as tumor suppressor), by Hippo (Hpo), which is in a complex with Salvador (Sav). Activated Warts phosphorylates and inhibits the transcriptional coactivator Yorkie (Yki), thereby suppressing cell growth and proliferation and allowing programmed cell death. merlin and expanded are also targets of Hippo signaling, creating a growth-suppressive feedback loop. Not all reported physical interactions or phosphorylations are shown.
sities, however, the growth suppressive activity of Merlin is dominant to mitogenic signaling, and thus it is difficult to view Merlin as a simple signal transduction component.
Alternative mechanisms, in line with the traditional view that ERM proteins form a structural linkage between transmembrane components and the actin cytoskeleton, are also interesting to consider (McClatchey and Giovanni, 2005) . Such alternatives do not necessarily require specific ligands or receptors as regulators of Merlin/Expanded function. In one scenario, Merlin and Expanded may act as structural components or regulators of cell structure-possibly compromising plasma membrane-cytoskeletal crosslinking when absent-and this would be sensed by the Hippo complex. This possibility seems consistent with the rounded cell-clone morphologies observed in Drosophila (Hamaratoglu et al., 2005) and the observation that Merlin is essential for the maintenance of adherens junctions in mouse embryonic fibroblasts (Lallemand et al., 2003) .
If Merlin and Expanded act as structural components, then numerous other regulators of cell adhesion and the cytoskeleton might also be expected to affect Hippo/Warts activity. Among the more intriguing genes to consider are the Src protooncogene, which encodes for a non-receptor tyrosine kinase, and its negative regulator encoded by C-Src kinase (csk). The literature implicating Src as a regulator of cell adhesion and actin cytoskeletal function is vast (Frame, 2004) , and both functions are consistent with genetic analysis in flies. Interestingly, loss of csk, which activates Src, causes overgrowth phenotypes in the fly eye that are not dissimilar to those observed in hpo, wts, or merlin, expanded mutants: interommatidial cells undergo ectopic proliferation and fail to be appropriately culled by apoptosis (Read et al., 2004) . In this case, the effects downstream of Src were attributed in part to activation of Jun-kinase and STAT signaling, but the potential involvement of the Hippo complex and Yorkie were not assessed. Interestingly, Nf2 mutant cells, which lack Merlin, also have increased Jun-kinase activity (Shaw et al., 2001) .
Another plausible role for Merlin and Expanded would be to act as sensors of a mechanical property, such as tension, at the membrane-cytoskeleton interface. In this capacity, they might provide a means for the Hippo complex to monitor cell-cell contact or adhesion. Growth suppression by cell-cell contact is of course well known in cell culture, and, as mentioned above, Merlin, Rac, and LATS2 mediate this response in several cell types (Lallemand et al., 2003; McPherson et al., 2004; Okada et al., 2005) . Though it is unclear whether contact inhibition is a useful concept for understanding how cell proliferation is contained during differentiation in vivo, the possibility is intriguing to consider. Developmental biologists sometimes assume that specific ligands and receptors must be used to arrest cell proliferation upon differentiation, but in fact there are few known signals that can be classified as dedicated differentiation signals. In Drosophila, signals that are used for patterning in early development (such as EGFR ligands, BMPs, Wnts, Notch ligands) are used again to drive differentiation (see for example, Firth and Baker [2005] ). As part of their job as promoters of differentiation and morphogenesis, these signals cause profound changes in cytoskeletal organization, cell adhesion, cell shape, and polarity. Hence, it may not be unreasonable to consider structural changes, such as increased adhesion or a stabilized cytoskeletal configuration, as the proximal trigger for cell cycle arrest upon differentiation. Merlin and Expanded might be used to sense, or orchestrate, these structural changes.
A Homeostat for Cell Structure?
In their studies of merlin and expanded, Hamaratoglu et al. (2005) discovered another intriguing phenomenon. They show that loss of hpo or wts causes a robust upregulation of Merlin and Expanded protein expression. This was attributed to increased levels of transcription, and thus (though it remains to be tested) the obvious expectation is that it is mediated via increased Yorkie activity. This negative feedback loop probably explains why loss of merlin upregulates expanded expression (McCartney et al., 2000) and so may explain how Merlin and Expanded complement each others' function. The potential impact of this feedback loop on cytoarchitecture and growth control is especially interesting to consider. Although the Drosophila studies have not yet detailed the effects of Merlin or Expanded on cell structure, expanded mutant wings do show evidence of altered cell shape , and studies of human Merlin indicate that it can alter adhesion, motility, and actin cytoskeletal morphology (Sun et al., 2002; Lallemand et al., 2003; McClatchey and Giovanni 2005) . If Merlin and Expanded were to act as both sensors of and regulators of cell structure, then feedback via Hippo signaling could generate a closed loop, or homeostat, that might maintain some critical cytoarchitectural parameter (such as plasma membrane-cytoskeletal tension) at an optimum. For example, decreased plasma membrane-cytoskeletal tension could suppress Hippo signaling and thereby enhance cell growth and survival, but also upregulate Merlin. The increased Merlin activity would then reestablish tension and activate Hippo signaling, rendering the growth response transient. Hence, the outlines of a mechanism of tissue homeostasis, as used in wound healing or contact inhibition, begin to emerge.
Hippo and Us
Drosophila researchers refer to hpo, sav, wts, and mats as "tumor suppressors" and have proposed that they will have a similar function in humans. Indeed, the components of this pathway are all well conserved, and some of the interactions observed in flies have been validated in mammalian cells. MST2 (Hippo) for instance, can activate LATS1 (Warts) (Chan et al., 2005) , and human Mats homologs (the MOB proteins) have been found to associate with multiple NDR type kinases homologous to Warts (Tamaskovic et al., 2003) . The evolutionary conservation is underscored by the demonstration that the human LATS1, MATS1, MST2, and YAP genes can all functionally rescue their respective Drosophila mutants in vivo. Therefore, it seems that the basic outlines of the pathway as deter-mined in flies will be conserved in humans. It is still unclear, however, whether the mammalian Yorkie ortholog, YAP, will account for the majority of LATS function, as Yorkie appears to do for Warts. YAP has been reported to work as a cofactor for a variety of human transcriptional regulators, including P73, P53BP-2, Runx2, SMAD7, ErbB4, PEBP2α, and hnRNPU, but the relevance of these to LATS or MST2 function is unknown. It is also puzzling that some of the described functions of YAP are opposite to those of Yorkie; for instance, YAP can promote apoptosis after DNA damage as a cofactor for P73 (Basu et al., 2003; Strano et al., 2001 ), whereas Yorkie is clearly an apoptosis suppressor in the fly eye. Furthermore, the potential connection between human Merlin and the LATS/MST2 complex remains wholly unexplored, as does the possibility that Rac and PAK regulate Warts/Hippo and LATS/MST2 signaling in flies and humans, respectively.
As suggested by the Drosophila mutant phenotypes, a number of the mammalian genes in this emerging pathway have already been associated with tumorigenesis, with varying degrees of confidence. These include Lats1 and Lats2 Takahashi et al., 2005) , hMats1, and Sav1/WW45 (Tapon et al., 2002) . NF2/Merlin, however, is the only one of these genes that is clearly causal for a human disease, neurofibromatosis, characterized by benign tumors of the central nervous system (McClatchey and Giovanni 2005) . Determining whether the others are important tumor suppressors, regulators of tissue organization that lack cancer-promoting capability, or regulators of a completely disparate process such as color vision (Mikeladze-Dvali et al., 2005) will require that more stringent in vivo tests be performed in mice, similar to the mosaic knockouts done in Drosophila. Even if these genes prove not to be tumor suppressors in humans, they are likely to play important roles in preventing benign dystrophic diseases and ensuring normal cell and tissue architecture in developing epithelial organs.
